Considering that miR-9, the mammalian homolog of miR-79, is predicted to target mammalian RNF146 (Figure 5—figure supplement 6) and that JNK signaling is highly conserved throughout evolution, it opens up the possibility of developing a new miRNA-based strategy against cancer. The gene discussed is MAPK8; the disease is cancer.